Literature DB >> 31729291

A Novel Drug Repositioning Approach Based on Integrative Multiple Similarity Measures.

Chaokun Yan1, Luping Feng1, Wenxiu Wang1, Jianlin Wang1, Ge Zhang1, Junwei Luo2.   

Abstract

BACKGROUND: Drug repositioning refers to discovering new indications for the existing drugs, which can improve the efficiency of drug research and development.
METHODS: In this work, a novel drug repositioning approach based on integrative multiple similarity measure, called DR_IMSM, is proposed. The process of integrative similarity measure contains three steps. First, a heterogeneous network can be constructed based on known drug-disease association, shared entities information for drug pairwise and diseases pairwise. Second, a deep learning method, DeepWalk, is used to capture the topology similarity for drug and disease. Third, a similarity integration and adjusting process is further conducted to obtain more comprehensive drug and disease similarity measure, respectively.
RESULTS: On this basis, a Bi-random walk algorithm is implemented in the constructed heterogeneous network to rank diseases for each drug. Compared with other approaches, the proposed DR_IMSM can achieve superior performance in terms of AUC on the gold standard datasets. Case studies further confirm the practical significance of DR_IMSM. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Drug repositioning; bi-randomzzm321990walk; deepwalk; heterogeneous network; logistic function; similarity measure.

Mesh:

Year:  2020        PMID: 31729291     DOI: 10.2174/1566524019666191115103307

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  1 in total

1.  Integrative resource for network-based investigation of COVID-19 combinatorial drug repositioning and mechanism of action.

Authors:  A K M Azad; Shadma Fatima; Alexander Capraro; Shafagh A Waters; Fatemeh Vafaee
Journal:  Patterns (N Y)       Date:  2021-07-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.